Bioatla Inc (BCAB)

Bioatla Inc (BCAB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.5M; returns 1 day +39.0%, 1 week +25.7%, 1 year -95.2%.

BioAtla, Inc. is a clinical-stage biopharmaceutical company based in San Diego, focused on developing novel antibody-based therapeutics for solid tumor cancers.

Groups BCAB belongs to

• Biotechnology
• Biopharmaceutical
• Recent Reverse Splits
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Antibody-Drug Conjugates
• Biologics
• Antibody Therapeutics
• Healthcare
• Clinical Stage
• Life Sciences
• Drug Discovery
• Bispecific Antibodies
• Precision Medicine

BCAB financial model: income statement, cash flow and balance sheet